Pharmacology and Toxicology
Showing page 15 of 22 pages of list content
-
Nucleotide Analogues as Inhibitors of Viral Polymerases
This article's authors -
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms
This article's authors -
Discovery of rhodomyrtone as a broad-spectrum antiviral inhibitor with anti-SARS-CoV-2 activity
This article's authors -
In Vitro Efficacy of “Essential Iodine Drops” Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2)
This article's authors -
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19
This article's authors -
Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening
This article's authors -
CETSA®MS profiling for a comparative assessment of FDA approved antivirals repurposed for COVID-19 therapy identifies Trip13 as a Remdesivir off-target
This article's authors -
In VitroActivity of Itraconazole Against SARS-CoV-2
This article's authors -
The Effect of Famotidine on SARS-CoV-2 Proteases and Virus Replication
This article's authors -
The hyperlipidaemic drug fenofibrate significantly reduces infection by SARS-CoV-2 in cell culture models
This article's authors